MyFinsight
Home
Blog
About
Effect of exchange rate
changes on cash, cash...
$813K
(-91.22%↓ Y/Y)
Net change in cash,
cash equivalents and...
-$108,360K
(-538.92%↓ Y/Y)
Canceled cashflow
$813K
something is missing
$20,258K
Stock-based compensation
$19,498K
(-25.46%↓ Y/Y)
Depreciation and
amortization
$18,167K
(-23.82%↓ Y/Y)
Accrued expenses and
other current...
$5,828K
(-48.78%↓ Y/Y)
Lease expense
$5,216K
(-7.27%↓ Y/Y)
Prepaid data assets
-$3,062K
(-23.97%↓ Y/Y)
Other, net
-$740K
(84.23%↑ Y/Y)
Equity incentive plans
$984K
Net cash used in
operating activities
-$105,947K
(-38.64%↓ Y/Y)
Net cash used in
investing activities
-$1,959K
(66.27%↑ Y/Y)
Net cash provided by
(used in) financing...
-$1,267K
(-101.30%↓ Y/Y)
Canceled cashflow
$72,769K
Canceled cashflow
$984K
Net loss
-$131,005K
(23.79%↑ Y/Y)
Purchase of an intangible
asset
$1,915K
(-11.26%↓ Y/Y)
Purchases of property and
equipment
$44K
(-98.60%↓ Y/Y)
Repayment of long-term
debt and finance...
$2,251K
(8.01%↑ Y/Y)
Accrued data liability
-$20,258K
(-200.00%↓ Y/Y)
Accounts payable
-$7,672K
(-58.61%↓ Y/Y)
Unearned revenue
-$7,304K
(46.38%↑ Y/Y)
Other receivables and
assets
$6,292K
(124.76%↑ Y/Y)
Lease liabilities
-$4,638K
(9.91%↑ Y/Y)
Accrued development
expense
-$1,544K
(-104.77%↓ Y/Y)
Deferred income taxes
-$3K
Back
Back
Cash Flow
6556d670e8da976dc91d11c4_Recursion Logo Horizontal Black-svg
source: myfinsight.com
RECURSION PHARMACEUTICALS, INC. (RXRX)
6556d670e8da976dc91d11c4_Recursion Logo Horizontal Black-svg
RECURSION PHARMACEUTICALS, INC. (RXRX)